Literature DB >> 11506198

T cell repertoire in primary biliary cirrhosis: a common T cell clone and repertoire change after treatment.

R Okamoto1, K Yamamoto, K Yabushita, N Okano, N Shimada, S Matsumura, M Mizuno, T Higashi, T Tsuji.   

Abstract

T cell repertoire was analyzed in three early-stage primary biliary cirrhosis (PBC) patients, using reverse transcription-polymerase chain reaction and single-strand conformation polymorphism. Multiple expanded clones were demonstrated in livers and peripheral blood lymphocytes (PBL) of all three patients. Comparison of the repertoire of different parts of the liver demonstrated the presence of common clones in various Vbeta families. Comparison of the repertoire between the liver and PBL demonstrated that both CD4 and CD8 T cell clones were expanded. Sequence analysis of complementarity determining region 3 of the expanded clones revealed that relatively conserved amino acids were utilized in each patient and that an identical CD4 T cell clone having Vbeta16 was present in all three patients. The number of expanded T cell clones in PBL decreased markedly after the treatment with prednisolone. These results suggest that common T cell clones may play a pathogenic role in PBC.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11506198     DOI: 10.1023/a:1010983325927

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  41 in total

1.  A controlled trial of prednisolone treatment in primary biliary cirrhosis. Three-year results.

Authors:  H C Mitchison; J M Palmer; M F Bassendine; A J Watson; C O Record; O F James
Journal:  J Hepatol       Date:  1992-07       Impact factor: 25.083

Review 2.  Primary biliary cirrhosis.

Authors:  M M Kaplan
Journal:  N Engl J Med       Date:  1996-11-21       Impact factor: 91.245

3.  Randomised controlled trials of ursodeoxycholic-acid therapy for primary biliary cirrhosis: a meta-analysis.

Authors:  J Goulis; G Leandro; A K Burroughs
Journal:  Lancet       Date:  1999-09-25       Impact factor: 79.321

4.  Combined analysis of randomized controlled trials of ursodeoxycholic acid in primary biliary cirrhosis.

Authors:  R E Poupon; K D Lindor; K Cauch-Dudek; E R Dickson; R Poupon; E J Heathcote
Journal:  Gastroenterology       Date:  1997-09       Impact factor: 22.682

5.  Characterisation of T cell clonotypes that accumulated in multiple joints of patients with rheumatoid arthritis.

Authors:  M Kurokawa; T Kato; K Masuko-Hongo; S Ueda; T Kobata; M Okubo; T Nishimaki; T Akaza; S Yoshino; R Kasukawa; K Nishioka; K Yamamoto
Journal:  Ann Rheum Dis       Date:  1999-09       Impact factor: 19.103

Review 6.  The V-region disease hypothesis: new evidence suggests it is probably wrong.

Authors:  D B Wilson; L Steinman; D P Gold
Journal:  Immunol Today       Date:  1993-08

7.  T cell clonality in synovial fluid of a patient with rheumatoid arthritis: persistent but fluctuant oligoclonal T cell expansions.

Authors:  T Kato; M Kurokawa; K Masuko-Hongo; H Sasakawa; T Sekine; S Ueda; K Yamamoto; K Nishioka
Journal:  J Immunol       Date:  1997-11-15       Impact factor: 5.422

8.  Is ursodeoxycholic acid an effective treatment for primary biliary cirrhosis?

Authors:  R Poupon; Y Chrétien; R E Poupon; F Ballet; Y Calmus; F Darnis
Journal:  Lancet       Date:  1987-04-11       Impact factor: 79.321

9.  Evidence for the effects of a superantigen in rheumatoid arthritis.

Authors:  X Paliard; S G West; J A Lafferty; J R Clements; J W Kappler; P Marrack; B L Kotzin
Journal:  Science       Date:  1991-07-19       Impact factor: 47.728

10.  Analysis of T cell receptor beta chains in Lewis rats with experimental allergic encephalomyelitis: conserved complementarity determining region 3.

Authors:  D P Gold; H Offner; D Sun; S Wiley; A A Vandenbark; D B Wilson
Journal:  J Exp Med       Date:  1991-12-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.